RecruitingNot ApplicableNCT06615453

Impact of Tixel Treatment on Symptoms and Signs in Patients With Dry Eye Disease

A Prospective Study Assessing the Impact of Tixel Treatment of Peri Orbital Wrinkles on Symptoms and Signs in Patients With Dry Eye Disease

Sponsor

Aston University

Enrollment

36 participants

Start Date

Sep 17, 2024

Study Type

INTERVENTIONAL

Conditions

Dry Eye Disease (DED)

Summary

This study will examine how a standard Tixel treatment versus a sham treatment for eye wrinkles affects the symptoms and signs of Dry Eye Disease.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Sham treatment and a medical device called Thermo-mechanical action based peri-orbital fractional skin treatment for people with dry eye disease (ded). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.